结合凝和MSC,提供可溶性TRAIL,以向胰腺腺癌及其流体

Giulia Grisendi1, Massimiliano Dall'Ora2, Giulia Casari3

  • 1Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia (UNIMORE), Modena, Italy.

Cell reports. Medicine
|August 21, 2024
PubMed
概括

这项研究表明,将凝胺化疗与分泌sTRAIL的修饰干细胞结合起来,可以有效地向胰腺癌细胞及其支持性纤维细胞. 这种方法在临床前模型中减少了瘤生长和转移.